|
RNF24 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.57549999999707E-05 |
| Normal-vs-Stage3 |
1.62891922173003E-12 |
| Normal-vs-Stage4 |
1.69469993593907E-11 |
| Stage1-vs-Stage2 |
6.773900E-02 |
| Stage1-vs-Stage3 |
8.431600E-01 |
| Stage1-vs-Stage4 |
9.991000E-01 |
| Stage2-vs-Stage3 |
1.345990E-01 |
| Stage2-vs-Stage4 |
1.192180E-01 |
| Stage3-vs-Stage4 |
8.884400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
2.38879999999719E-05 |
| Normal-vs-Asian |
1.51760004563073E-09 |
| Caucasian-vs-AfricanAmerican |
7.247000E-01 |
| Caucasian-vs-Asian |
8.950800E-01 |
| AfricanAmerican-vs-Asian |
6.982200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
9.980500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
7.26360083191935E-11 |
| Normal-vs-Age(81-100Yrs) |
4.003900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.095600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.006180E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.396830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.025420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.468000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.669000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.621800E-01 |
| Classical-VS-Follicular |
1.25455201782643E-13 |
| Classical-VS-Other |
1.109840E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
1.89597999999958E-05 |
| Tall-VS-Other |
1.232800E-01 |
| Tall-VS-Normal |
3.13689999531519E-08 |
| Follicular-VS-Other |
4.515000E-01 |
| Follicular-VS-Normal |
2.444100E-04 |
| Other-VS-Normal |
2.663900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62436730732907E-12 |
| Normal-vs-N1 |
1.17489995510311E-09 |
| N0-vs-N1 |
3.332000E-01 |
|
|
